Label: PANCREVED- pancreatic enzyme tablet

  • NDC Code(s): 50989-312-51, 50989-312-52
  • Packager: Vedco, INC
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated May 13, 2020

If you are a consumer or patient please visit this version.

View All Sections

  • PancreVed Tablets

    PANCREATIC ENZYME CONCENTRATE

    VEDCO

    KEEP OUT OF REACH OF CHILDREN

    CAUTION: Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

  • FOR ANIMAL USE ONLY

  • Each tablet contains a minimum of:

    Lipase.........................9,000 USP units

    Protease...................57,000 USP units

    Amylase....................64,000 USP units

    DESCRIPTION:

    PancreVed is a pancreatic enzyme concentrate of porcine origin.

  • TAKE TIME OBSERVE LABEL DIRECTIONS

    Manufactured by Neogen Corporation

    Lexington, KY 40511

    Distributed by:

    VEDCO, INC

    St. Joseph, MO 64507

    Made in USA

  • DOSAGE:

    Dose is administered before each meal. Estimate dose according to the severity of the condition and weight of the animal.

    Average dose/meal:

    Dogs - 2 - 3 tablets

    Cats - ½ - 1 tablet

  • INDICATIONS:

    As a digestive aid in replacement therapy where digestion of protein, carbohydrate and fat is inadequate due to exocrine pancreatic insufficiency.

  • PRECAUTIONS:

    Discontinue use in animals with symptoms of sensitivity or allergy.

  • Store tightly closed container in a dry place at room temperature.

  • PRINCIPAL DISPLAY PANEL - VEDCO PancreVed Tabs 100 Tablet Bottle

    NDC 50989-312-51

    PancreVed Tablets

    PANCREATIC ENZYME CONCENTRATE

    NET CONTENTS: 100 TABLETS

    VEDCO

    KEEP OUT OF REACH OF CHILDREN

    CAUTION: Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

    PancreVed Tablets 100ct

  • PRINCIPAL DISPLAY PANEL - VEDCO PancreVed Tabs 500 Tablet Bottle

    NDC 50989-312-52

    PancreVed Tablets

    PANCREATIC ENZYME CONCENTRATE

    NET CONTENTS: 500 TABLETS

    VEDCO

    KEEP OUT OF REACH OF CHILDREN

    CAUTION: Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

    PancreVed Tablets 500ct

  • INGREDIENTS AND APPEARANCE
    PANCREVED 
    pancreatic enzyme tablet
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:50989-312
    Route of Administrationoral
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PANCRELIPASE LIPASE (UNII: 8MYC33932O) (PANCRELIPASE LIPASE - UNII:8MYC33932O) PANCRELIPASE LIPASE9000 [iU]
    PANCRELIPASE AMYLASE (UNII: YOJ58O116E) (PANCRELIPASE AMYLASE - UNII:YOJ58O116E) PANCRELIPASE AMYLASE64000 [iU]
    PANCRELIPASE PROTEASE (UNII: 3560D81V50) (PANCRELIPASE PROTEASE - UNII:3560D81V50) PANCRELIPASE PROTEASE57000 [iU]
    Product Characteristics
    ColorbrownScoreno score
    ShapeROUNDSize11mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:50989-312-51100 in 1 BOTTLE, PLASTIC
    2NDC:50989-312-52500 in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other11/08/2012
    Labeler - Vedco, INC (021634266)
    Establishment
    NameAddressID/FEIBusiness Operations
    Scientific Protein Laboratories LLC065240319analysis, api manufacture
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events (Animal Drug), FDA Safety Recalls (Animal Drug)

Related Resources

Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!